Identifying novel breast cancer subtypes effect on clinical response to neoadjuvant chemotherapy

被引：0
|
作者：
Bhatt, N. [1 ]
Fiuza-Castinieria, C. [1 ]
Murphy, S. [1 ]
O'Connor, M. [1 ]
O'Donoghue, G. T. [1 ]
机构：
[1] Waterford Reg Hosp, Waterford, Ireland
来源：
BRITISH JOURNAL OF SURGERY | 2014年 / 101卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：22 / 22
页数：1
相关论文
共 50 条
  • [31] Vitamin D deficiency in various breast cancer subtypes and its impact on response to neoadjuvant chemotherapy in operable breast cancer
    Raman, R.
    Link, B. K.
    Mott, S. L.
    Schroeder, M. C.
    Thomas, A.
    CANCER RESEARCH, 2016, 76
  • [32] Prediction of breast cancer response to neoadjuvant chemotherapy in different biological breast cancer subtypes using diffuse optical tomography
    Altoe, Mirella L.
    Kalinsky, Kevin M.
    Guo, Hua
    Hibshoosh, Hanina
    Tejada, Mariella
    Crew, Katherine D.
    Accordino, Melissa K.
    Trivedi, Meghna S.
    Marone, Alessandro
    Kim, Hyun K.
    Hielscher, Andreas H.
    Hershman, Dawn L.
    CANCER RESEARCH, 2022, 82 (04)
  • [33] Breast cancer subtyping by immunohistochemistry and histological grade outperforms breast cancer intrinsic subtypes in predicting neoadjuvant chemotherapy response
    Lips, E. H.
    Mulder, L.
    de Ronde, J. J.
    Mandjes, I. A. M.
    Koolen, B. B.
    Wessels, L. F. A.
    Rodenhuis, S.
    Wesseling, J.
    BREAST CANCER RESEARCH AND TREATMENT, 2013, 140 (01) : 63 - 71
  • [34] Breast cancer subtyping by immunohistochemistry and histological grade outperforms breast cancer intrinsic subtypes in predicting neoadjuvant chemotherapy response
    E. H. Lips
    L. Mulder
    J. J. de Ronde
    I. A. M. Mandjes
    B. B. Koolen
    L. F. A. Wessels
    S. Rodenhuis
    J. Wesseling
    Breast Cancer Research and Treatment, 2013, 140 : 63 - 71
  • [35] Clinical Outcomes Among Major Breast Cancer Subtypes After Neoadjuvant Chemotherapy: Impact on Breast Cancer Recurrence and Survival
    Orsaria, Paolo
    Grasso, Antonella
    Ippolito, Edy
    Pantano, Francesco
    Sammarra, Matteo
    Altomare, Carlo
    Cagli, Barbara
    Costa, Fabio
    Perrone, Giuseppe
    Soponaru, Georgeta
    Caggiati, Lorenza
    Vanni, Gianluca
    Buonomo, Oreste Claudio
    Altomare, Vittorio
    ANTICANCER RESEARCH, 2021, 41 (05) : 2697 - 2709
  • [36] Response and survival of breast cancer intrinsic subtypes following multi-agent neoadjuvant chemotherapy
    Prat, Aleix
    Fan, Cheng
    Fernandez, Aranzazu
    Hoadley, Katherine A.
    Martinello, Rossella
    Vidal, Maria
    Viladot, Margarita
    Pineda, Estela
    Arance, Ana
    Munoz, Montserrat
    Pare, Laia
    Cheang, Maggie C. U.
    Adamo, Barbara
    Perou, Charles M.
    BMC MEDICINE, 2015, 13
  • [37] Relevance of breast cancer subtypes for magnetic resonance imaging response monitoring during neoadjuvant chemotherapy
    Cesar Gómez-Raposo
    Mónica Andreu
    Inés Suárez-García
    M. Isabel Esteban
    Mar Carballo
    María F. Sereno-Moyano
    José L. Vázquez Osorio
    Javier Heras
    Francisco Zambrana Tévar
    Eva Pelayo
    Miriam López-Gómez
    Clara García de Santiago
    María Merino Salvador
    Enrique Casado
    Clinical and Translational Oncology, 2012, 14 : 486 - 488
  • [38] Response and survival of breast cancer intrinsic subtypes following multi-agent neoadjuvant chemotherapy
    Aleix Prat
    Cheng Fan
    Aranzazu Fernández
    Katherine A. Hoadley
    Rossella Martinello
    Maria Vidal
    Margarita Viladot
    Estela Pineda
    Ana Arance
    Montserrat Muñoz
    Laia Paré
    Maggie C. U. Cheang
    Barbara Adamo
    Charles M. Perou
    BMC Medicine, 13
  • [39] Neoadjuvant Chemotherapy (NC) Response in Patients with Breast Cancer According to Immunohistochemical Intrinsic Subtypes (IHC)
    Ruvalcaba Limon, Eva
    Barreda Zelaya, Lilian Elizabeth
    Garcia Orozco, Nathaly
    Morales Vasquez, Flavia
    Bautista Pina, Veronica
    Maffuz Aziz, Antonio
    Rodriguez Cuevas, Sergio
    GACETA MEDICA DE MEXICO, 2014, 150 : 161 - 170
  • [40] Prediction of the treatment response to neoadjuvant chemotherapy in breast cancer by subtypes using tumor infiltrating lymphocytes
    Kashiwagi, S.
    Asano, Y.
    Goto, W.
    Morisaki, T.
    Noda, S.
    Takashima, T.
    Onoda, N.
    Hirakawa, K.
    CANCER RESEARCH, 2016, 76
12345